The NTG brought together a national panel of expert researchers and practitioners in the field of Down syndrome and Alzheimer’s disease, including LuMind IDSC’s Scientific Chief Officer, Dr. James Hendrix, […]
Today, individuals with Down syndrome enjoy a longer life expectancy and are now able to live into their sixties. Unfortunately, there’s a new challenge that people with Down syndrome and […]
October 18, 2021 Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts, recently published an article in the Journal of Applied Research in Intellectual Disabilities, that delves into […]
October 18, 2021 October is Down Syndrome Awareness Month, and to commemorate it, Hampus Hillerstrom, LuMind IDSC’s CEO, wrote an article for the Exceptional Parent Magazine, a publication that serves the […]
In June, the FDA granted “accelerated approval” to Biogen’s Aduhelm drug. This is the first new drug approved for Alzheimer’s disease since 2003. It is also the first approved drug […]
October 7, 2021 From mom of four to Down syndrome researcher. Research Spotlight sat with Nicole White and discussed some of the challenges that prevent parents and caregivers from getting […]
